American Regent

Executive Summary

American Regent is a privately held U.S. pharmaceutical company specializing in the development, manufacturing, and supply of essential injectable medicines. Founded in 1982 and headquartered in Shirley, New York, the company focuses on hospital and critical care injectables, including iron replacement therapies, emergency medications, and trace elements. With a mission to improve patient and animal lives through consistent supply, American Regent operates in the generic and branded generic drug sectors. The company's established presence in the injectable market positions it as a reliable partner for healthcare providers, leveraging its manufacturing capabilities and regulatory expertise. As a private entity, American Regent maintains a low public profile but remains a significant player in the generic injectable space, particularly in high-demand therapeutic categories.

Upcoming Catalysts (preview)

• Q3 2026FDA Approval of New Generic Injectable Product70% success
• TBDExpansion of Manufacturing Capacity85% success
• Q4 2026Strategic Partnership for Iron Replacement Therapies60% success